|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 23.66 USD | -1.29% |
|
-6.63% | -30.43% |
Company Valuation: Assembly Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111.5 | 63.41 | 53.96 | 100.3 | 537.9 | 481.7 | - | - |
| Change | - | -43.14% | -14.91% | 85.89% | 436.32% | -10.45% | - | - |
| Enterprise Value (EV) 1 | 111.5 | 63.41 | 53.96 | 100.3 | 537.9 | 395.2 | 354.8 | 243.1 |
| Change | - | -43.14% | -14.91% | 85.89% | 436.32% | -26.53% | -10.22% | -31.5% |
| P/E | -0.78x | -0.68x | -0.74x | -2.36x | -61.8x | -203x | -8.67x | -18.4x |
| PBR | - | - | - | - | - | 1.16x | 1.24x | 1.09x |
| PEG | - | 0x | 0x | 0x | 0.7x | 2.6x | -0x | 0.3x |
| Capitalization / Revenue | 17.8x | - | 7.53x | 3.52x | 7.44x | 7.59x | 14.1x | 9.88x |
| EV / Revenue | 17.8x | - | 7.53x | 3.52x | 7.44x | 6.23x | 10.4x | 4.98x |
| EV / EBITDA | - | - | - | - | -44.9x | 11.3x | -11.7x | -15.5x |
| EV / EBIT | -1.22x | -0.67x | -0.83x | -2.21x | -44.4x | -18.5x | -5.2x | -7.45x |
| EV / FCF | - | -0.75x | - | - | -13.1x | 41.2x | 19x | 5.71x |
| FCF Yield | - | -133% | - | - | -7.65% | 2.43% | 5.27% | 17.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -36 | -23.04 | -13.38 | -6.69 | -0.55 | -0.1165 | -2.728 | -1.284 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6.254 | - | 7.163 | 28.52 | 72.3 | 63.43 | 34.12 | 48.78 |
| EBITDA 1 | - | - | - | - | -11.99 | 35.11 | -30.44 | -15.7 |
| EBIT 1 | -91.05 | -94.11 | -64.65 | -45.42 | -12.12 | -21.37 | -68.29 | -32.64 |
| Net income 1 | -129.9 | -93.09 | -61.23 | -40.18 | -6.122 | 1.403 | -56.83 | -27.27 |
| Net Debt 1 | - | - | - | - | - | -86.48 | -126.9 | -238.6 |
| Reference price 2 | 27.96 | 15.60 | 9.84 | 15.78 | 34.01 | 23.66 | 23.66 | 23.66 |
| Nbr of stocks (in thousands) | 3,988 | 4,065 | 5,483 | 6,356 | 15,817 | 20,361 | - | - |
| Announcement Date | 3/11/22 | 3/22/23 | 3/28/24 | 3/20/25 | 3/19/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -203.11x | 6.23x | 11.26x | - | 482M | |
| 33.31x | 5.98x | 17.9x | 0.97% | 48.01B | |
| 35.42x | 3.39x | 14.64x | -.--% | 45.27B | |
| 47.15x | 5.46x | 29.88x | -.--% | 40.93B | |
| -20.54x | 221.64x | -22.17x | -.--% | 42.84B | |
| 26.85x | 7.74x | 19.93x | 0.42% | 29.6B | |
| 35.29x | 5.79x | 26.32x | -.--% | 17.32B | |
| 25.91x | 2.22x | 9.63x | 1.03% | 15.34B | |
| -59.05x | 9.67x | 236.13x | -.--% | 14.84B | |
| Average | -8.75x | 29.79x | 38.17x | 0.3% | 28.29B | |
| Weighted average by Cap. | 19.96x | 41.90x | 25.52x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ASMB Stock
- Valuation Assembly Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
